Table 1.
Clinical and demographic characteristics of study cohorts
| HIV-positive test cohort (n=32) | HIV-positive validation cohort (n=36) | HIV-negative cohort (n=36) | |
|---|---|---|---|
| Age (years)* | 44 (33-59) | 48 (35-57) | 49 (36-62) |
| Gender (male) | 67% | 53% | 53% |
| Race (African American) | 60% | 86% | 78% |
| BMI* | 23.6 (21.9-30.1) | 25.3 (18.6-34.6) | 26.1 (19.4-39.9) |
| HCV seropositive | 73% | 67% | 64% |
| Smokers | NA | 81% | 78% |
| Alcohol use | 40% | 53% | 50% |
| Cocaine use | 47% | 53% | 56% |
| % on ART | 100% | 58% | NA |
| % on PI | 77% | 68% | NA |
| Current CD4 (cells/ul)* | 288 (16-1396) | 350 (64-992) | NA |
| Nadir CD4 (cells/ul)* | 54 (2-267) | 227 (6-856) | NA |
| Plasma HIV viral load (log copies/ml)* | 1.7 (1.7-3.2) | 2.8 (1.6-4.0) | NA |
| BDI* | 9 (0-35) | NA | NA |
| % with BDI ≥ 14 | 47% | NA | NA |
| CES-D* | NA | 11 (0-43) | 12 (0-36) |
| % with CES-D ≥ 16 | NA | 36% | 33% |
| Antidepressant use | 30% | 27% | 16% |
*
Median (IQR)
Abbreviations: BMI, body mass index; BDI, Beck Depression Inventory; CES-D, Center for Epidemiological Studies Depression Scale; NA, not available.